Johnson & Johnson (JNJ) was the top performer among defensive stocks in 2026, with a year-to-date gain of 35% as of last Friday's close, outperforming Coca-Cola's (KO) 28% increase and Procter & Gamble's (PG) 4% increase over the same period. JNJ's growth was primarily driven by its oncology and immunology product lines.